Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/22/2010 | CN101433588B Method for producing five-ester dropping pills |
12/22/2010 | CN101416958B Use of 15-methano-substituted-andrographolide derivative in preparing anti-hepatitis B medicine |
12/22/2010 | CN101411808B Method for preparing Chinese medicine for treating heat intestine and stomach type constipation |
12/22/2010 | CN101401900B Chinese medicinal composition for treating gastric, duodenal ulcer |
12/22/2010 | CN101391088B Enterogastritis oral medicine |
12/22/2010 | CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
12/22/2010 | CN101284041B Compound radix astragali Chinese medicinal formulations with health-care function |
12/22/2010 | CN101279072B Chinese medicine capsule for curing digestive system disease |
12/22/2010 | CN101264051B Modified release pharmaceutical formulation |
12/22/2010 | CN101239058B Proanhocyanidins compounds for preparing medicaments and health care food for preventing and controlling helicobacter pylori associated gastritis |
12/22/2010 | CN101239037B Acetylcysteine injection and preparation thereof |
12/22/2010 | CN101209342B Application of helianthus tuberosus agglutinin in preparing medicine for treating constipation and delaying stomach and intestine retrogradation |
12/22/2010 | CN101208330B Method of preparing esomeprazole and salts thereof |
12/22/2010 | CN101181373B Cortex moutan valid target pharmaceutical combination, preparation method and application thereof |
12/22/2010 | CN101128436B Glycine derivative and use thereof |
12/22/2010 | CN101103755B Method for producing convenient nutritive rice-tea and product |
12/22/2010 | CN101095951B Therapeutic HBV DNA vaccines, method for preparing the same and application thereof |
12/22/2010 | CN101040650B Health-care type ganoderma lucidum combined tea |
12/21/2010 | US7855288 For treatment of cytokine-associated conditions |
12/21/2010 | US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
12/21/2010 | US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders |
12/21/2010 | US7855202 useful in the treatment respiratory system disorders, allergic diseases, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, gastrointestinal disorders and/or autoimmune diseases |
12/21/2010 | US7855198 Benzamide derivative or salt thereof |
12/21/2010 | US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases |
12/21/2010 | US7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
12/21/2010 | US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
12/21/2010 | CA2609494C Motilide compounds |
12/21/2010 | CA2569654C Benzimidazolone carboxylic acid derivatives |
12/21/2010 | CA2492718C Prodrugs of proton pump inhibitors |
12/21/2010 | CA2483345C Imidazolinylmethyl aralkylsulfonamides |
12/21/2010 | CA2470109C Substituted phenyl naphthalenes as estrogenic agents |
12/21/2010 | CA2453823C Dermal therapy using phosphate derivatives of electron transfer agents |
12/21/2010 | CA2434337C Combination of probiotics |
12/21/2010 | CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds |
12/21/2010 | CA2412004C Glucagon-like peptide-1 analogs |
12/21/2010 | CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
12/21/2010 | CA2371517C An improving agent for hypoalbuminaemia |
12/16/2010 | WO2010144865A2 Methods for treating gastrointestinal disorders |
12/16/2010 | WO2010144502A2 Growth hormone polypeptides and methods of making and using same |
12/16/2010 | WO2010144498A2 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
12/16/2010 | WO2010144446A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors |
12/16/2010 | WO2010144140A2 Egfr and par2 regulation of intestinal permeability |
12/16/2010 | WO2010144055A1 Novel compounds and uses thereof |
12/16/2010 | WO2010144044A1 Use of a composition for the treatment of mucositis |
12/16/2010 | WO2010143101A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals. |
12/16/2010 | WO2010142997A1 Use of a serum composition to reduce the levels of tnf and/or vegf in mammals |
12/16/2010 | WO2009144555A8 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
12/16/2010 | US20100319073 GDE Compositions and Methods |
12/16/2010 | US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties |
12/16/2010 | US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions |
12/16/2010 | US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field |
12/16/2010 | US20100317689 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
12/16/2010 | US20100317664 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein |
12/16/2010 | US20100317661 Small molecule inhibitors of mdm2 and the uses thereof |
12/16/2010 | US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
12/16/2010 | US20100317650 Imidazopyridine derivatives useful as inos inhibitors |
12/16/2010 | US20100317649 S1P Receptor Modulating Compounds and Use Thereof |
12/16/2010 | US20100317643 Janus kinase inhibitor compounds and methods |
12/16/2010 | US20100317626 The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD |
12/16/2010 | US20100317572 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
12/16/2010 | US20100316727 Treatment of inflammatory disorders with ozone |
12/16/2010 | US20100316709 Orally disintegrating solid preparation |
12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
12/16/2010 | US20100316627 Human antibodies to human IL-6 receptor |
12/16/2010 | US20100316624 Treatment of fibroses and liver disorders |
12/16/2010 | US20100316617 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
12/16/2010 | US20100316611 Self-containing lactococcus strain |
12/16/2010 | US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling |
12/16/2010 | CA2765075A1 Egfr and par2 regulation of intestinal permeability |
12/16/2010 | CA2765033A1 Methods for treating gastrointestinal disorders |
12/16/2010 | CA2764981A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamoylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors |
12/16/2010 | CA2764587A1 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
12/16/2010 | CA2764105A1 Growth hormone polypeptides and methods of making and using same |
12/16/2010 | CA2763092A1 Use of a composition for the treatment of mucositis |
12/15/2010 | EP2261216A2 Pyrazoles as glucokinase activators |
12/15/2010 | EP2261210A1 3-substituted sulfonyl piperazine derivative |
12/15/2010 | EP2261206A1 Indolinone compound |
12/15/2010 | EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor |
12/15/2010 | EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof |
12/15/2010 | EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents |
12/15/2010 | EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens |
12/15/2010 | EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
12/15/2010 | EP2260832A2 Optimal polymer mixtures for gastric retentive tablets |
12/15/2010 | EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes |
12/15/2010 | EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
12/15/2010 | EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
12/15/2010 | EP1807084B1 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis |
12/15/2010 | EP1444523B1 Screening for hepatitis c virus entry inhibitors |
12/15/2010 | EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof |
12/15/2010 | EP1053001B1 Novel mixed amylin activity compounds |
12/15/2010 | CN1969924B Pharmaceutical composition of Silibinin and isatis root |
12/15/2010 | CN1872166B Drop pills of magnolia vine fruit kernel and preparation method |
12/15/2010 | CN1857489B Preparing process of hemp seed soft capsule for treating constipation |
12/15/2010 | CN1857334B Glossy ganoderma spore oil emulsion for intravenous injection and its preparing method |
12/15/2010 | CN1708480B Carotenoid analogs for the inhibition and amelioration of disease |
12/15/2010 | CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents |
12/15/2010 | CN101918391A Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
12/15/2010 | CN101918017A Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome |
12/15/2010 | CN101918014A Medicinal composition |
12/15/2010 | CN101918013A Use of lactobacillus casei for increasing the protection provided by the influenza vaccine |